Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 1.29M | 1.09M | 1.46M | 2.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 1.29M | 1.09M | 1.46M | 2.55M |
| Cost of Revenue | 11.02M | 8.60M | 11.26M | 18.36M | 16.91M |
| Gross Profit | -11.02M | -7.31M | -10.17M | -16.90M | -14.36M |
| SG&A Expenses | 9.42M | 8.58M | 9.06M | 10.30M | 10.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.44M | 17.18M | 20.33M | 28.66M | 27.57M |
| Operating Income | -20.44M | -15.88M | -19.24M | -27.20M | -25.02M |
| Income Before Tax | -19.53M | -49.41M | -18.06M | -25.77M | -23.39M |
| Income Tax Expenses | 95.00K | 636.00K | -- | 1.00K | -- |
| Earnings from Continuing Operations | -19.63M | -50.04M | -18.06M | -25.77M | -23.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.63M | -50.04M | -18.06M | -25.77M | -23.39M |
| EBIT | -20.44M | -15.88M | -19.24M | -27.20M | -25.02M |
| EBITDA | -20.06M | -15.23M | -18.06M | -25.98M | -23.80M |
| EPS Basic | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 |
| Normalized Basic EPS | -1.05 | -0.99 | -1.20 | -1.72 | -1.56 |
| EPS Diluted | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 |
| Normalized Diluted EPS | -1.05 | -0.99 | -1.20 | -1.72 | -1.56 |
| Average Basic Shares Outstanding | 11.60M | 9.42M | 9.39M | 9.39M | 9.38M |
| Average Diluted Shares Outstanding | 11.60M | 9.42M | 9.39M | 9.39M | 9.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |